SPOTLIGHT -
EP. 1: Pathobiology of Acute Myeloid Leukemias (AML)
EP. 2: Development of Secondary Acute Myeloid Leukemias
EP. 3: Risk Stratification of Myelodysplastic Syndromes and AML
EP. 4: Prognostic Factors in Acute Myeloid Leukemia
EP. 5: Prognostic Factors in Acute Myeloid Leukemia Treatment
EP. 6: Evolution in Acute Myeloid Leukemia Induction Strategies
EP. 7: Consolidation Strategies in AML Treatment
EP. 8: Management of Primary Refractory AML
EP. 9: Emerging Therapeutic Approaches in AML
EP. 10: Immunotherapy in Acute Myeloid Leukemia
EP. 11: The Importance of Supportive Care in AML
EP. 12: Infection Prophylaxis in Acute Myeloid Leukemia
EP. 13: Multidisciplinary Team in Acute Myeloid Leukemia
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
